Cochrane Kidney and Transplant reviews

Our Reviews

Full list:

By subtopic:

ACUTE KIDNEY INJURY (22)
Anticoagulation (1)
Pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy (protocol stage)
Antihypertensive agents (0)
Atrial natriuretic peptide (1)
Atrial natriuretic peptide for preventing and treating acute kidney injury
Contrast-induced nephropathy (0)
Diuretics (0)
Dopamine and dopamine antagonists (1)
Fenoldopam for preventing and treating acute kidney injury (protocol stage)
Growth factors (0)
Haemolytic uraemic syndrome (3)
Interventions for atypical haemolytic uraemic syndrome (protocol stage)
Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura
Interventions for preventing diarrhoea-associated haemolytic uraemic syndrome (protocol stage)
Hyperkalaemia (2)
Emergency interventions for hyperkalaemia
Pharmacological interventions for the acute management of hyperkalaemia in adults
Nutrition (1)
Nutritional support for acute kidney injury
Plasma volume expanders (0)
Post cardiac surgery (1)
HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass
Renal replacement therapy (9)
Bicarbonate- versus lactate-buffered solutions for acute continuous haemodiafiltration or haemofiltration
Intensity of continuous renal replacement therapy for acute kidney injury
Intermittent versus continuous renal replacement therapy for acute renal failure in adults
Continuous renal replacement therapy (CRRT) for rhabdomyolysis
Peritoneal dialysis for acute kidney injury
Biocompatible hemodialysis membranes for acute renal failure
Tidal versus other forms of peritoneal dialysis for acute kidney injury
Timing of renal replacement therapy initiation for acute kidney injury
Bicarbonate versus lactate solutions for acute peritoneal dialysis
Sodium bicarbonate supplements (1)
Sodium bicarbonate supplements for treating acute kidney injury
Statins (1)
HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass
Thyroid hormones (1)
Thyroid hormones for acute kidney injury
CHRONIC KIDNEY DISEASE (82)
General management (48)
Acidosis control (1)
Correction of chronic metabolic acidosis for chronic kidney disease patients
Anaemia control (9)
Androgens for the anaemia of chronic kidney disease in adults
Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease
Darbepoetin for the anaemia of chronic kidney disease
Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis
Parenteral versus oral iron therapy for adults and children with chronic kidney disease
Oral iron for people with chronic kidney disease (protocol stage)
Haemoglobin and haematocrit targets for the anaemia of chronic kidney disease
Short-acting erythropoiesis-stimulating agents for anaemia in predialysis patients
Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis
Antihypertensive agents (3)
Aldosterone antagonists for preventing the progression of chronic kidney disease
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease
Calcium channel blockers for people with chronic kidney disease requiring dialysis (protocol stage)
Bone and mineral disease (7)
Dietary interventions for mineral and bone disorder in people with chronic kidney disease
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
Interventions for metabolic bone disease in children with chronic kidney disease
Magnesium-based interventions for people with chronic kidney disease (protocol stage)
Pharmacological interventions for osteoporosis in people with chronic kidney disease stages 3-5D (protocol stage)
Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Vitamin D compounds for people with chronic kidney disease not requiring dialysis
Cardiovascular risk management (7)
Altered dietary salt intake for people with chronic kidney disease
Antiplatelet agents for chronic kidney disease
Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease
Interventions for weight loss in people with chronic kidney disease who are overweight or obese (protocol stage)
Antioxidants for chronic kidney disease
Pharmacological interventions for heart failure in people with chronic kidney disease (protocol stage)
HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis
Endocrine - other (3)
Interventions for treating sexual dysfunction in patients with chronic kidney disease
Metformin for preventing the progression of chronic kidney disease (protocol stage)
Growth hormone for children with chronic kidney disease
Lifestyle and complimentary therapies (6)
Alternate therapies (4)
Acupuncture and related interventions for symptoms of chronic kidney disease
Astragalus (a traditional Chinese medicine) for treating chronic kidney disease
Cordyceps sinensis (a traditional Chinese medicine) for treating chronic kidney disease
Rheum officinale (a traditional Chinese medicine) for chronic kidney disease
Exercise (1)
Exercise training for adults with chronic kidney disease
Psychosocial (1)
Interventions for treating sexual dysfunction in patients with chronic kidney disease
Nutrition (5)
Altered dietary salt intake for people with chronic kidney disease
Dietary interventions for adults with chronic kidney disease
Low protein diets for non-diabetic adults with chronic kidney disease
Protein restriction for children with chronic kidney disease
Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
Other (7)
eHealth interventions for people with chronic kidney disease
Interventions for improving health literacy in people with chronic kidney disease (protocol stage)
Interventions for itch in people with advanced chronic kidney disease (protocol stage)
Interventions for improving sleep quality in people with chronic kidney disease
Treatment for hepatitis C virus-associated mixed cryoglobulinaemia
Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease
Oral adsorbents for preventing or delaying the progression of chronic kidney disease
Genetic disorders (3)
Anderson-Fabry disease (1)
Enzyme replacement therapy for Anderson-Fabry disease
Cystinosis (0)
Polycystic kidney disease (2)
Interventions for infected cysts in people with autosomal dominant polycystic kidney disease (protocol stage)
Interventions for preventing the progression of autosomal dominant polycystic kidney disease
Glomerular diseases (30)
Diabetic kidney disease (13)
Dietary interventions (3)
Altered dietary salt intake for preventing and treating diabetic kidney disease
Protein restriction for diabetic renal disease
Vitamin B and its derivatives for diabetic kidney disease
Education programmes (1)
Education programmes for people with diabetic kidney disease
Pharmacological interventions (9)
Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease
Direct renin inhibitors for preventing the progression of diabetic kidney disease (protocol stage)
Antihypertensive agents for preventing diabetic kidney disease
Glucose targets for preventing diabetic kidney disease and its progression
Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients
Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease
Pentoxifylline for diabetic kidney disease
Prostaglandin E1 for preventing the progression of diabetic kidney disease
Heparin and related substances for preventing diabetic kidney disease
Focal segmental glomerulosclerosis (1)
Immunosuppressive treatment for focal segmental glomerulosclerosis in adults
HIV-associated nephropathy (1)
Interventions for HIV-associated nephropathy
Henoch-Schönlein Purpura (HSP) (1)
Interventions for preventing and treating kidney disease in Henoch-Schönlein Purpura (HSP)
IgA nephropathy (2)
Immunosuppressive agents for treating IgA nephropathy
Non-immunosuppressive treatment for IgA nephropathy
Lupus nephritis (1)
Immunosuppressive treatment for proliferative lupus nephritis
Membranoproliferative glomerulonephritis (0)
Membranous nephropathy (1)
Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome
Minimal change nephropathy (1)
Interventions for minimal change disease in adults with nephrotic syndrome
Nephrotic syndrome (8)
Chinese herbal medicine Huangqi type formulations for nephrotic syndrome
Corticosteroid therapy for nephrotic syndrome in children
Human albumin infusion for treating oedema in people with nephrotic syndrome
Interventions for idiopathic steroid-resistant nephrotic syndrome in children
Lipid-lowering agents for nephrotic syndrome
Interventions for preventing infection in nephrotic syndrome
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children
Hook F (a traditional Chinese medicine) for primary nephrotic syndrome
Rapidly progressive glomerulonephritis (1)
Interventions for renal vasculitis in adults
Investigations, procedures and process of care (1)
Referral strategies (1)
Early referral to specialist nephrology services for preventing the progression to end-stage kidney disease
DIAGNOSTIC TEST ACCURACY REVIEWS (5)
Acute pyelonephritis (1)
Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children
cytomegalovirus (CMV) diagnostic tests (0)
Iron measurements (0)
Other (1)
Clinical symptoms, signs and tests for identification of impending and current water-loss dehydration in older people
Renal scarring (0)
Suprapubic urine aspiration (0)
Transplantation (2)
Cardiac testing for coronary artery disease in potential kidney transplant recipients
Galactomannan detection for invasive aspergillosis in immunocompromised patients
Vesicoureteric reflux (1)
Dimercaptosuccinic acid scan or ultrasound in screening for vesicoureteral reflux among children with urinary tract infections
Ureteric colic (0)
DRUGS AND THE KIDNEY (7)
Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer
Effects of peri-operative nonsteroidal anti-inflammatory drugs on post-operative kidney function for adults with normal kidney function
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function
Loop diuretics for patients receiving blood transfusions
Effects of nonsteroidal anti-inflammatory drugs on postoperative renal function in adults with normal renal function
Teicoplanin versus vancomycin for proven or suspected infection
Amphotericin B deoxycholate versus liposomal amphotericin B: effects on kidney function
DRUGS: OTHER (1)
Loop diuretics for patients receiving blood transfusions
ELECTROLYTE DISORDERS (2)
Interventions for chronic non-hypovolaemic hypotonic hyponatraemia
Potassium binders for chronic hyperkalaemia in people with chronic kidney disease (protocol stage)
END-STAGE KIDNEY DISEASE (67)
General management (29)
Anaemia control (3)
Early versus delayed erythropoietin for the anaemia of end-stage kidney disease
Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients
Interventions for erythropoietin-resistant anaemia in dialysis patients
Antihypertensive agents (0)
Bone and mineral disease (1)
Vitamin D compounds for people with chronic kidney disease requiring dialysis
Cardiovascular risk management (3)
Aldosterone antagonists (1)
Aldosterone antagonists for people with chronic kidney disease requiring dialysis (protocol stage)
Cholesterol (1)
HMG CoA reductase inhibitors (statins) for dialysis patients
Homocysteine (1)
Interventions for lowering plasma homocysteine levels in dialysis patients
Endocrine - other (0)
Infection (5)
Dressings for the prevention of surgical site infection
Hepatitis B vaccination for patients with chronic renal failure
Frequency of dressing changes for central venous access devices on catheter-related infections
Interventions for dialysis patients with hepatitis C virus (HCV) infection
Isolation as a strategy for controlling the transmission of hepatitis C virus (HCV) infection in haemodialysis units
Lifestyle and complimentary therapies (3)
Other (1)
Interventions to aid employment for people on dialysis and their families (protocol stage)
Psychosocial (2)
Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis
Psychosocial interventions for preventing and treating depression in dialysis patients
Nutrition (3)
Interventions for promoting adherence to fluid intake and dietary salt restriction in people with end-stage kidney disease (protocol stage)
Oral protein-based supplements for people with chronic kidney disease requiring dialysis (protocol stage)
Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride
Other (6)
Dry mouth (2)
Interventions for the management of dry mouth: topical therapies
Interventions for the management of dry mouth: non-pharmacological interventions
Fatigue (1)
Interventions for fatigue in people with chronic kidney disease requiring dialysis (protocol stage)
Pruritus (itching) (1)
Interventions for itch in people with advanced chronic kidney disease (protocol stage)
Restless legs (2)
Interventions for chronic kidney disease-associated restless legs syndrome
Opioids for restless legs syndrome
Treatment options (5)
Dialysis (3)
Continuous ambulatory peritoneal dialysis (CAPD) versus hospital or home haemodialysis for end-stage renal disease in adults
Urgent-start peritoneal dialysis versus conventional-start peritoneal dialysis for people with chronic kidney disease (protocol stage)
Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney disease (protocol stage)
Palliative care (1)
Advance care planning for haemodialysis patients
Transplantation (1)
Pre-emptive versus non pre-emptive kidney transplantation for end-stage kidney disease (protocol stage)
Haemodialysis (28)
Access (8)
Catheters (2)
Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults
Interventions for treating central venous haemodialysis catheter malfunction
Contrast agents (0)
Fluid control (0)
Needling devices (0)
Vascular access (6)
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease
Omega-3 fatty acids for dialysis vascular access outcomes in patients with chronic kidney disease
Pre-emptive correction for haemodialysis arteriovenous access stenosis
Preoperative vascular access evaluation for haemodialysis patients
Ultrasound use for the placement of haemodialysis catheters
Upper limb exercise for haemodialysis fistula surgery (protocol stage)
Anticoagulation (3)
Anticoagulants and antiplatelet agents for preventing central venous haemodialysis catheter malfunction in patients with end-stage kidney disease
Anticoagulation for people receiving long-term haemodialysis (protocol stage)
Non-pharmacological interventions for preventing clotting of extracorporeal circuits during continuous renal replacement therapy (protocol stage)
Dialysate (2)
Low dialysate sodium levels for chronic haemodialysis
Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis
Dialysers (2)
Membranes (2)
High-flux versus low-flux membranes for end-stage kidney disease
Cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease
Ultrafiltration control (0)
Haemodialysis delivery (3)
Treatment options (3)
Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease
Haemodialysis duration, frequency and intensity for end-stage kidney disease (protocol stage)
Home versus in-centre haemodialysis for end-stage kidney disease
Infection - prevention and treatment (6)
Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis
Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults
Dressings for the prevention of surgical site infection
Interventions for preventing infectious complications in haemodialysis patients with central venous catheters
Skin antisepsis for reducing central venous catheter-related infections
Surgical hand antisepsis to reduce surgical site infection
Other (2)
Human albumin for intradialytic hypotension in haemodialysis patients
Upper limb exercise for people on haemodialysis following arteriovenous fistula surgery (protocol stage)
Thrombosis / patency (2)
Interventions for thrombosed haemodialysis arteriovenous fistulas and grafts (protocol stage)
Medical adjuvant treatment to increase patency of arteriovenous fistulae and grafts
Peritoneal dialysis (10)
Catheters (3)
Catheter placement (2)
Catheter insertion techniques for improving catheter function and clinical outcomes in peritoneal dialysis patients (protocol stage)
Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients
Transfer systems (1)
Double bag or Y-set versus standard transfer systems for continuous ambulatory peritoneal dialysis in end-stage kidney disease
Dialysate (1)
Solutions (1)
Biocompatible dialysis fluids for peritoneal dialysis
Infection - prevention and treatment (4)
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients
Catheter type, placement and insertion techniques for preventing catheter-related infections in chronic peritoneal dialysis patients
Surgical hand antisepsis to reduce surgical site infection
Treatment for peritoneal dialysis-associated peritonitis
Other (1)
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients
Peritoneal dialysis delivery (1)
Treatment options (1)
Continuous ambulatory peritoneal dialysis versus automated peritoneal dialysis for end-stage renal disease
PROCESS OF CARE (8)
END-OF-LIFE CARE (2)
End-of-life care pathways for improving outcomes in caring for the dying
Hospital at home: home-based end-of-life care
END-STAGE KIDNEY DISEASE (0)
OTHER (5)
Discharge planning from hospital
Follow-up services for improving long-term outcomes in intensive care unit (ICU) survivors
Interventions for improving outcomes in patients with multimorbidity in primary care and community settings
Interventions to improve adherence to lipid-lowering medication
Shared care across the interface between primary and specialty care in management of long term conditions
SCREENING TESTS (1)
Screening with urinary dipsticks for reducing morbidity and mortality
TRANSPLANTATION (0)
URINARY TRACT INFECTION (0)
TRANSPLANTATION: KIDNEY (42)
Acute rejection (3)
Antibody therapy (3)
Belatacept for kidney transplant recipients
Interventions for treating antibody-mediated acute rejection in kidney transplant recipients (protocol stage)
Polyclonal and monoclonal antibodies for treating acute rejection episodes in kidney transplant recipients
Complications and co-interventions (15)
Antihypertensive treatment (1)
Antihypertensive treatment for kidney transplant recipients
Bone and mineral disease (1)
Interventions for preventing bone disease in kidney transplant recipients
Cardiovascular risk (4)
Fish oil for kidney transplant recipients
HMG CoA reductase inhibitors (statins) for kidney transplant recipients
Interventions for lowering plasma homocysteine levels in kidney transplant recipients
Interventions for post-transplant anaemia in kidney transplant recipients (protocol stage)
Diabetes (0)
Infection (7)
Prevention (5)
Antifungal agents for preventing fungal infections in solid organ transplant recipients
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients (protocol stage)
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
Treatment (2)
Antibiotics for asymptomatic bacteriuria in kidney transplant recipients
Interventions for BK virus infection in kidney transplant recipients (protocol stage)
Nutrition (1)
Fish oil for kidney transplant recipients
Other (1)
(a traditional Chinese medicine) for kidney transplant recipients
Induction therapy / primary immunosuppression (6)
Antibody therapy (3)
Belatacept for kidney transplant recipients
Interleukin 2 receptor antagonists for kidney transplant recipients
Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients
Antiproliferative agents (1)
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients
Calcineurin inhibitors (1)
Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients
Target of rapamycin inhibitors (mTOR-I) (1)
Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients
Maintenance immunosuppression (2)
Calcineurin inhibitors (1)
Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients
Steroids (1)
Steroid avoidance or withdrawal for kidney transplant recipients
Organ donation (1)
Interventions for increasing solid organ donor registration (protocol stage)
Other (1)
(a traditional Chinese medicine) for kidney transplant recipients
Transplantation procedures (14)
Procedural (6)
Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients
Cardiac testing for coronary artery disease in potential kidney transplant recipients
Dressings for the prevention of surgical site infection
Protocol biopsies following kidney transplantation (protocol stage)
Ischaemic preconditioning for the reduction of renal ischaemia reperfusion injury
Surgical hand antisepsis to reduce surgical site infection
Surgical (8)
Donors (3)
Laparoscopic versus open nephrectomy for live kidney donors
Laparoendoscopic single-site donor nephrectomy (LESS-DN) versus standard laparoscopic donor nephrectomy
Machine perfusion preservation versus static cold storage for deceased donor kidney transplantation
Recipients (5)
Early versus late ureteric stent removal after kidney transplantation
Graft nephrectomy for people with a failed kidney transplant (protocol stage)
Minimally invasive surgical techniques for kidney transplantation (protocol stage)
Normal saline versus lower-chloride solutions for kidney transplantation
Routine intraoperative ureteric stenting for kidney transplant recipients
TRANSPLANTATION: KIDNEY-PANCREAS (10)
Complications and co-interventions (5)
Infection (5)
Prevention (5)
Antifungal agents for preventing fungal infections in solid organ transplant recipients
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients (protocol stage)
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
Treatment (0)
Nutrition (0)
Induction therapy / primary immunosuppression (1)
Antibody therapy (1)
Antibody immunosuppression for pancreas and kidney-pancreas transplant recipients (protocol stage)
Antiproliferative agents (0)
Calcineurin inhibitors (0)
Target of rapamycin inhibitors (mTOR-I) (0)
Maintenance immunosuppression (1)
Steroids (1)
Steroid avoidance or withdrawal for pancreas and pancreas with kidney transplant recipients
Organ donation (1)
Interventions for increasing solid organ donor registration (protocol stage)
Other (0)
Transplantation procedures (2)
Procedures (2)
Dressings for the prevention of surgical site infection
Surgical hand antisepsis to reduce surgical site infection
Surgery (0)
TRANSPLANTATION: LUNG (2)
Chronic lung allograft dysfunction (CLAD) (1)
Azithromycin for treatment of bronchiolitis obliterans syndrome in adult lung transplant recipients (protocol stage)
Lifestyle and complimentary therapies (1)
Exercise training for adult lung transplant recipients (protocol stage)
TRANSPLANTATION: SOLID ORGAN (19)
Complications and co-interventions (7)
Infection (6)
Prevention (6)
Antifungal agents for preventing fungal infections in solid organ transplant recipients
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
Perioperative antibiotics for preventing post-surgical site infections in solid organ transplant recipients (protocol stage)
Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients
Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipients
Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis
Treatment (0)
Malignancy (1)
Interventions for preventing non-melanoma skin cancers in high-risk groups
Nutrition (0)
Induction therapy / primary immunosuppression (4)
Antibody induction therapy for lung transplant recipients
Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients
Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis
Tacrolimus versus cyclosporin as primary immunosuppression for lung transplant recipients
Maintenance immunosuppression (2)
Glucocorticosteroid-free versus glucocorticosteroid-containing immunosuppression for liver transplanted patients
Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis
Organ donation (1)
Interventions for increasing solid organ donor registration (protocol stage)
Other (2)
Exercise-based cardiac rehabilitation in heart transplant recipients
Interventions for improving medication adherence in solid organ transplant recipients (protocol stage)
Transplantation procedures (3)
Procedures (2)
Dressings for the prevention of surgical site infection
Surgical hand antisepsis to reduce surgical site infection
Surgical (1)
Recipients (1)
Interventions for preventing thrombosis in solid organ transplant recipients (protocol stage)
URINARY TRACT INFECTION (23)
Diagnosis (1)
Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children
Prevention and prophylaxis (9)
Cranberries for preventing urinary tract infections
Interventions for preventing recurrent urinary tract infection during pregnancy
Long-term antibiotics for preventing recurrent urinary tract infection in children
Methenamine hippurate for preventing urinary tract infections
Routine neonatal circumcision for the prevention of urinary tract infections in infancy
Antibiotics for preventing recurrent urinary tract infection in non-pregnant women
Oestrogens for preventing recurrent urinary tract infection in postmenopausal women
Probiotics for preventing urinary tract infections in adults and children
Probiotics for preventing urinary tract infection in people with neuropathic bladder
Treatment (13)
Asymptomatic urinary tract infection (2)
Antibiotics for asymptomatic bacteriuria
Interventions for covert bacteriuria in children
Lower urinary tract infection (10)
Antibiotic duration for treating uncomplicated, symptomatic lower urinary tract infections in elderly women
Antibiotics for treating lower urinary tract infection in children
Antimicrobial agents for treating uncomplicated urinary tract infection in women
Chinese herbal medicine for treating recurrent urinary tract infections in women
Duration of antibacterial treatment for uncomplicated urinary tract infection in women
Modes of administration of antibiotics for symptomatic severe urinary tract infections
Short versus standard duration oral antibiotic therapy for acute urinary tract infection in children
Cranberries for treating urinary tract infections
Quinolones for uncomplicated acute cystitis in women
Urinary alkalisation for symptomatic uncomplicated urinary tract infection in women
Pyelonephritis (1)
Antibiotics for acute pyelonephritis in children
Urine collection (0)
Urological and surgical procedures (0)
UROLOGY (1)
VESICOURETERIC REFLUX (1)
Treatment (1)
Interventions for primary vesicoureteric reflux